Safety, Reactogenicity, and Immunogenicity of mRNA-1345, an Investigational Respiratory Syncytial Virus Vaccine, in Participants Aged 2 to < 18 Years at High Risk of Severe Disease

The requested reference [d7fac657387abba5a39700c739136277d33904f3] no longer exists in our database. It has been replaced by the current reference: [5095d2b9a9f7141a2d10b644142ce70dca0e5290]

Authors
Category Primary study
JournalOpen Forum Infect. Dis.
Year 2025
This article has no abstract
Epistemonikos ID: c0797cc3d6a582d0c854162aad242b53ed2c1d21
First added on: Jun 14, 2025